John Wiley & Sons, Inc. (WLY)
48.19
-2.47
(-4.88%)
USD |
NYSE |
Sep 04, 16:00
48.03
-0.16
(-0.33%)
Pre-Market: 20:00
John Wiley & Sons R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical R&D to Revenue (TTM) Data
| Date | Value |
|---|---|
| January 31, 1999 | -- |
| October 31, 1998 | -- |
| July 31, 1998 | -- |
| April 30, 1998 | -- |
| January 31, 1998 | -- |
| October 31, 1997 | -- |
| July 31, 1997 | -- |
| April 30, 1997 | -- |
| Date | Value |
|---|---|
| January 31, 1997 | -- |
| October 31, 1996 | -- |
| July 31, 1996 | -- |
| April 30, 1996 | -- |
| January 31, 1996 | -- |
| October 31, 1995 | -- |
| July 31, 1995 | -- |
| April 30, 1995 | -- |
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.
R&D to Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median